iSTAR Medical has completed 40 million euros in Series C financing to be used in the development of its MINIject device for the treatment of glaucoma, according to a press release.
Health care specialist funds LSP and Gimv led the funding round, with participation from Earlybird, BNP Paribas Fortis Private Equity, Capricorn Partners, Walloon Region Investment Fund and Belgian Federal Investment Fund.
“We are delighted to welcome LSP, Gimv, Earlybird and BNP Paribas Fortis Private Equity to iSTAR Medical, and I would like to thank our existing investors for their (Read more...)
Uncategorized